Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

814 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
De novo expression of fetal ED-A(+) fibronectin and B (+) tenascin-C splicing variants in human cardiac allografts: potential impact for targeted therapy of rejection.
Franz M, Matusiak-Brückner M, Richter P, Grün K, Ziffels B, Neri D, Maschek H, Schulz U, Pfeil A, Jung C, Figulla HR, Gummert J, Berndt A, Renner A. Franz M, et al. Among authors: richter p. J Mol Histol. 2014 Oct;45(5):519-32. doi: 10.1007/s10735-014-9573-4. Epub 2014 May 3. J Mol Histol. 2014. PMID: 24792713
Extra cellular matrix remodelling after heterotopic rat heart transplantation: gene expression profiling and involvement of ED-A+ fibronectin, alpha-smooth muscle actin and B+ tenascin-C in chronic cardiac allograft rejection.
Franz M, Grün K, Richter P, Brehm BR, Fritzenwanger M, Hekmat K, Neri D, Gummert J, Figulla HR, Kosmehl H, Berndt A, Renner A. Franz M, et al. Among authors: richter p. Histochem Cell Biol. 2010 Nov;134(5):503-17. doi: 10.1007/s00418-010-0750-6. Epub 2010 Oct 8. Histochem Cell Biol. 2010. PMID: 20931338
Changes in extra cellular matrix remodelling and re-expression of fibronectin and tenascin-C splicing variants in human myocardial tissue of the right atrial auricle: implications for a targeted therapy of cardiovascular diseases using human SIP format antibodies.
Franz M, Brehm BR, Richter P, Gruen K, Neri D, Kosmehl H, Hekmat K, Renner A, Gummert J, Figulla HR, Berndt A. Franz M, et al. Among authors: richter p. J Mol Histol. 2010 Feb;41(1):39-50. doi: 10.1007/s10735-010-9260-z. Epub 2010 Mar 16. J Mol Histol. 2010. PMID: 20232238
Comparative analysis of oncofetal fibronectin and tenascin-C expression in right atrial auricular and left ventricular human cardiac tissue from patients with coronary artery disease and aortic valve stenosis.
Baldinger A, Brehm BR, Richter P, Bossert T, Gruen K, Hekmat K, Kosmehl H, Neri D, Figulla HR, Berndt A, Franz M. Baldinger A, et al. Among authors: richter p. Histochem Cell Biol. 2011 May;135(5):427-41. doi: 10.1007/s00418-011-0809-z. Epub 2011 Apr 10. Histochem Cell Biol. 2011. PMID: 21479812
Differential vascular expression and regulation of oncofetal tenascin-C and fibronectin variants in renal cell carcinoma (RCC): implications for an individualized angiogenesis-related targeted drug delivery.
Galler K, Junker K, Franz M, Hentschel J, Richter P, Gajda M, Göhlert A, von Eggeling F, Heller R, Giavazzi R, Neri D, Kosmehl H, Wunderlich H, Berndt A. Galler K, et al. Among authors: richter p. Histochem Cell Biol. 2012 Feb;137(2):195-204. doi: 10.1007/s00418-011-0886-z. Epub 2011 Nov 11. Histochem Cell Biol. 2012. PMID: 22075565
814 results